National record and analysis of pharmaceutical interventions in critical care units: PHARMACRITIC study.

Autor:	Cerezuela MM; Servicio de Farmacia, Hospital Universitari i Politècnic La Fe, Valencia, España., Becerril Moreno F; Servicio de Farmacia, Hospital Can Misses, Ibiza, España., Amor García MÁ; Servicio de Farmacia, Hospital Universitario Infanta Cristina, Madrid, España., Bastida Fernández C; Servicio de Farmacia, Hospital Clinic de Barcelona, Barcelona, España., Aquerreta González I; Servicio de Farmacia, Clínica Universidad de Navarra, Pamplona, España., Cobo Sacristán S; Servicio de Farmacia, Hospital Universitari de Bellvitge, Barcelona, España., Egüés Lugea A; Servicio de Farmacia, Complejo Hospitalario de Navarra, Pamplona, España., Albanell Fernández M; Servicio de Farmacia, Hospital Clinic de Barcelona, Barcelona, España., Doménech Moral L; Servicio de Farmacia, Hospital Universitari Vall d'Hebron, Barcelona, España., Fernández Polo A; Servicio de Farmacia, Hospital Universitari Vall d'Hebron, Barcelona, España., Betancor García T; Servicio de Farmacia, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Tenerife, España., Ortiz Pérez S; Servicio de Farmacia, Hospital Universitario 12 de Octubre, Madrid, España., Domingo Chiva E; Servicio de Farmacia, Gerencia de Atención Integrada de Albacete, Albacete, España. Electronic address: edomingo@sescam.jccm.es.
Jazyk:	English; Spanish; Castilian
Zdroj:	Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Jun 17. Date of Electronic Publication: 2024 Jun 17.
DOI:	10.1016/j.farma.2024.05.008
Abstrakt:	Objective: To design a homogeneous methodology for the registration and analysis of pharmaceutical interventions performed in Spanish critical adults' care units. Method: Observational, prospective and multicenter study. In the first stage, a national registry of pharmaceutical interventions will be agreed upon and subsequently all the pharmaceutical interventions performed on adult patients admitted to Spanish CCUs during eight weeks will be recorded. Variables related to the type of CCU, the drug involved in the intervention, type of intervention (indication, effectiveness, safety), recommendation made by the pharmacist and the degree of acceptance will be evaluated. Risk and incidence will be calculated for each of the medication errors detected. The χ2-squared test or Fisher exact test will be used for categorical variables and Mann-Whitney U or Kruskal-Wallis test for continuous variables. All tests will be performed with a significance level α = 0.05 and confidence intervals with confidence 1- α. Discussion: The results obtained from this project will make it possible to obtain a homogeneous classification of the pharmaceutical interventions performed in CCU, a national record and an evaluation of the weak points with the aim of developing strategies for improvement in the pharmaceutical care of the critically ill patient. (Copyright © 2024. Publicado por Elsevier España, S.L.U.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu